https://www.unodc.org/unodc/en/data-and-analysis/wdr2021_annex.html. Accessed 24 June 2021
Statistics Canada (2018) National Cannabis Survey, first quarter 2018. Retrieved 29 Oct 2018 from: https://www150.statcan.gc.ca/n1/daily-quotidien/180418/dq180418b-eng.htm.
The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. https://www.ncbi.nlm.nih.gov/books/NBK425767/ Accessed 24 June 2021
Aviram J, Samuelly-Leichtag G. Efficacy of cannabis-based medicines for pain management: a systematic review and meta-analysis of randomized controlled trials. Pain Phys. 2017;20:E755–96.
https://libraryguides.nau.edu/c.php?g=665927&p=4682772, Accessed 9 Aug 2021
Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014;370(23):2219–27. https://doi.org/10.1056/NEJMra1402309.
Windle SB, Wade K, Filion KB, Kimmelman J, Thombs BD, Eisenberg MJ. Potential harms from legalization of recreational cannabis use in Canada. Can J Public Health. 2019;110(2):222–6. https://doi.org/10.17269/s41997-018-00173-1.
Gov’t of Canada. Canadian Cannabis Survey 2020: Summary. https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/canadian-cannabis-survey-2020-summary.html. Accessed 24 June 2021
Cascini F, Aiello C, Di Tanna G. Increasing delta-9-tetrahydrocannabinol (Delta-9-THC) content in herbal cannabis over time: systematic review and meta-analysis. Curr Drug Abuse Rev. 2012;5:32–40.
Potter DJ, Clark P, Brown MB. Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology. J Forensic Sci. 2008;53:90–4.
Savaki HE, Cunha J, Carlini EA, Kephalas TA. Pharmacological activity of three fractions obtained by smoking cannabis through a water pipe. Bull Narc. 1976;28:49–56.
King B, Jones C, Baldwin G, Priss B. The EVALI and youth vaping epidemics — implications for public health. N Engl J Med. 2020;382:689–91. https://doi.org/10.1056/NEJMp1916171.
Outbreak of lung injury associated with the use of e-cigarette, or vaping, products. centre for diseases control and prevention. https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html. Accessed 27 June 2021
Tashkin DP, et al. Tar, CO and delta 9THC delivery from the 1st and 2nd halves of a marijuana cigarette. Pharmacol Biochem Behav. 1991;40:657–61.
Wu TC, Tashkin DP, Djahed B, Rose JE. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med. 1988;318:347–51.
Birrer RB, Calderon J. Pneumothorax, pneumomediastinum, and pneumopericardium following Valsalva’s maneuver during marijuana smoking. NY State J Med. 1984;84:619–20.
Vuolo F, et al. Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma. Eur J Pharmacol. 2019;843:251–9.
National Academies of Sciences, Engineering, and Medicine. The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. Washington: The National Academies Press; 2017.
Moir D, Rickert WS, Levasseur G, Larose Y, Maertens R, White P. Desjardins SA comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol. 2008;21(2):494–502.
Tashkin D. Effects of marijuana smoking on the lung. Ann Am Thorac Soc. 2013;10(3):239–47.
Ribeiro l, Ind P. Effect of cannabis smoking on lung function and respiratory symptoms: a structured literature review. Npj Prim Care Respir Med. 2016;26:16071. https://doi.org/10.1038/npjpcrm.2016.71.
Grinspoon L. Marijuana. Sci Am. 1969;221:17–25.
Nadel JA, Comroe JH Jr. Acute effects of inhalation of cigarette smoke on airway conductance. J Appl Physiol. 1961;16:713–6.
Tashkin DP, Shapiro BJ, Frank IM. Acute pulmonary physiologic effects of smoked marijuana and oral Δ9-tetrahydrocannabinol in healthy young men. N Engl J Med. 1973;289:336–41.
Tashkin DP, Shapiro BJ, Frank IM. Acute effects of smoked marijuana and oral Δ9-tetrahydrocannabinol on specific airway conductance in asthmatic subjects. Am Rev Respir Dis. 1974;109:420–8.
Vachon L, Fitzgerald MX, Solliday NH, Gould IA, Gaensler EA. Single-dose effect of marijuana smoke: bronchial dynamics and respiratory center sensitivity in normal subjects. N Engl J Med. 1973;288:985–9.
Tashkin DP, Shapiro BJ, Frank IM. Acute effects of marihuana on airway dynamics in spontaneous and experimentally induced bronchial asthma. In: Braude M, Szara S, editors. Pharmacology of marihuana. New York: Raven Press; 1976. p. 785–801.
Schwin R, Goodwin D, Hill S. Marihuana and tidal volume. JAMA. 1973;223(2):194–5.
Calignano A, Katona I, Desarnaud F, Giuffrida A, La Rana G, Mackie K, Freund TF, Piomelli D. Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature. 2000;408(2):96–101.
Williams W, Hartely JP, Graham JD. Bronchodilator effect of tetrahydrocannabinol administered by aerosol to asthmatic patients. Thorax. 1976;31:720.
Hancox RJ, et al. Effects of cannabis on lung function: a population-based cohort study. Eur Respir J. 2010;35:42–7.
Kempker JA, Honig EG, Martin GS. The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the US National Health and Nutrition Examination Study. Ann Am Thorac Soc. 2015;12:135–41.
Fligiel SE, et al. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest. 1997;112:319–26.
Tashkin DP, Coulson AH, Clark VA, Simmons M, Bourque LB, Duann S, Spivey GH, Gong H. Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis. 1987;135:209–16.
Bloom JW, Kaltenborn WT, Paoletti P, Camilli A, Lebowitz MD. Respiratory effects of non-tobacco cigarettes. Br Med J (Clin Res Ed). 1987;295:1516–8.
Polen MR, Sidney S, Tekawa IS, Sadler M, Friedman GD. Health care use by frequent marijuana smokers who do not smoke tobacco. West J Med. 1993;158:596–601.
Taylor DR, Poulton R, Moffitt TE, Ramankutty P, Sears MR. The respiratory effects of cannabis dependence in young adults. Addiction. 2000;95:1669–77.
Aldington S, Williams M, Nowitz M, Weatherall M, Pritchard A, McNaughton A, Robinson G, Beasley R. Effects of cannabis on pulmonary structure, function and symptoms. Thorax. 2007;62:1058–63.
Tan WC, Lo C, Jong A, Xing L, Fitzgerald MJ, Vollmer WM, Buist SA, Sin DD, Vancouver Burden of Obstructive Lung Disease (BOLD) Research Group. Marijuana and chronic obstructive lung disease—a population-based study. CMAJ. 2009;180:814–20.
James W, Barnes N, Stone I. The prevalence and impact of cannabis smoking in clinical trials of COPD. ERJ. 2015;46:337. https://doi.org/10.1183/13993003.congres-s2015.PA337.
Tashkin DP, Simmons M, Tseng C-H. Impact of changes in regular use of marijuana and/or tobacco on chronic bronchitis. COPD. 2012;9:367–74.
Hancox RJ, Shin HH, Gray AR, Poulton R, Sears MR. Effects of quitting cannabis on respiratory symptoms. Eur Respir J. 2015;46:80–7.
Alberg AJ, Ford JG, Samet JM, American College of Chest Physicians. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd). Chest. 2007;132:29S-55S.
Maertens RM, White PA, Rickert W, et al. The genotoxicity of mainstream and sidestream marijuana and tobacco smoke condensates. Chem Res Toxicol. 2009;22:1406–14.
Mehra R, Moore BA, Crothers K. The association between marijuana smoking and lung cancer: a systematic review. Arch Intern Med. 2006;166:1359–67.
Moir D, Rickert WS, Levasseur G, et al. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol. 2008;21:494–502.
Marselos M, Karamanakos P. Mutagenicity, developmental toxicity and carcinogenicity of cannabis. Addict Biol. 1999;4:5–12.
Tashkin DP, Baldwin GC, Sarafian T, Dubinett S, Roth MD. Respiratory and immunologic consequences of marijuana smoking. J Clin Pharmacol. 2002;42:71S-81S.
Barsky SH, Roth MD, Kleerup EC, Simmons M, Tashkin DP. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst. 1998;90(16):1198–205. https://doi.org/10.1093/jnci/90.16.1198.
Auerbach O, Stout AP, Hammond ED, Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking and its relation to lung cancer. N Engl J Med. 1961;265:253–67.
Fligiel SEG, Roth MD, Kleerup EC, Barsky SH, Simmons MS, Tashkin DP. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest. 1997;112:319–26.
Zhang LR, et al. Cannabis smoking and lung cancer risk: pooled analysis in the International Lung Cancer Consortium. Int J Cancer. 2015;136:894–903.
Sidney S, Quesenberry CP Jr, Friedman GD, Tekawa IS. Marijuana use and cancer incidence (California, United States). Cancer Causes Control. 1997;8:722–8.
Callaghan RC, Allebeck P, Sidorchuk A. Marijuana use and risk of lung cancer: a 40-year cohort study. Cancer Causes Control. 2013;24:1811–20.
Sanchez C, de Ceballos ML, Gomez del Pulgar T, Rueda D, Corbacho C, Velasco G, Galve-Roperh I, Huffman JW, Ramon y Cajal S, Guzman M. Inhibition of glioma growth in vivo by selective activation of the CB2 cannabinoid receptor. Cancer Res. 2001;61:5784–9.
Olea-Herrero N, Vara D, Malagarie-Cazenave S, Diaz-Laviada I. Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(1)-methanandamide and JWH-015: involvement of CB2. Br J Cancer. 2009;101:940–50.
Vara D, Salazar M, Olea-Herrero N, Guzman M, Velasco G, Diaz- LI. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Cell Death Differ. 2011;18:1099–111.
Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya S. An analysis of risk factors for oral cancer in young people: a case– control study. Oral Oncol. 2004;40:304–13.
Llewellyn CD, Johnson NW, Warnakulasuriya AAS. Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case–control study in southern England. J Oral Pathol Med. 2004;33:525–32.
Sidney S, Beck JE, Tekawa IS, Quesenberry CP, Friedman GD. Marijuana use and cancer incidence. Am J Public Health. 1997;87:585–90.
Aldington S, Harwood M, Cox B, Weatherall M, Beckert L, Hansell A, Pritchard A, Robinson G, Beasley R, Cannabis and Respiratory Disease Research Group. Cannabis use and risk of lung cancer: a case–control study. Eur Respir J. 2008;31:280–6.
Aldington S, Harwood M, Cox B, et al. Cannabis use and cancer of the head and neck: case-control study. Otolaryngol Head Neck Surg. 2008;138(3):374–80. https://doi.org/10.1016/j.otohns.2007.12.002.
Kim J, Hua G, Zhang H, Chan TJ, Xie M, Levin M, Farrokhyar F, Archibald SD, Jackson B, Young JE, Gupta M. Rate of second primary head and neck cancer with cannabis use. Cureus. 2020;12(11): e11483. https://doi.org/10.7759/cureus.11483.
Feng BJ, Khyatti M, Ben-Ayoub W, et al. Cannabis, tobacco and domestic fumes intake are associated with nasopharyngeal carcinoma in North Africa. Br J Cancer. 2009;101(7):1207–12. https://doi.org/10.1038/sj.bjc.6605281.
Sidney S, Quesenberry CP Jr, Friedman GD, Tekawa IS. Marijuana use and cancer incidence (California, United States). Cancer Causes Control. 1997;8(5):722–8. https://doi.org/10.1023/a:1018427320658.
Parker J, et al. Characteristics and 12-Week Outcomes for Marijuana Smokers in Subjects With Asthma Treated in the Emergency Department for an Asthma Exacerbation. Chest. 2012;142:733A. https://doi.org/10.1378/chest.1382146.
Decuyper II, Van Gasse AL, Cop N, et al. Cannabis sativa allergy: looking through the fog. Allergy. 2017;72:201e206.
Silvers W, Bernard T. Spectrum and prevalence of reactions to marijuana in a Colorado allergy practice. Lett Ann Allergy Asthma Immunol. 2017;119:570–1.
Tessmer A, Berlin N, Sussman G, et al. Hypersensitivity reactions to marijuana. Ann Allergy Asthma Immunol. 2012;108:282e284.
Kagen SL, Kurup VP, Sohnle PG, et al. Marijuana smoking and fungal sensitization. J Allergy Clin Immunol. 1983;71:389e393.
Silvers WS. A Colorado allergist’s experience with marijuana legalization. Ann Allergy Asthma Immunol. 2016;116:175e177.
Cary RM, et al. Pleuritic chest pain and fluid levels on imaging in a heavy cannabis smoker. BMJ Case Rep. 2015. https://doi.org/10.1136/bcr-2014-208064.
Hashmi HR, Duncalf R, Khaja M. A case report of cannabis induced hemoptysis. Medicine (Baltimore). 2016;95(13): e3232. https://doi.org/10.1097/MD.0000000000003232.
Beshay M, Kaiser H, Niedhart D, Reymond MA, Schmid RA. Emphysema and secondary pneumothorax in young adults smoking cannabis. Eur J Cardiothorac Surg. 2007;32(6):834–8. https://doi.org/10.1016/j.ejcts.2007.07.039.
Richman LS, Whitaker J, Kinnard WV. A case of acute hypersensitivity pneumonitis due to cannabis dabbing. Drug Induc Lung Dis Case Rep. 2018;1:A6636–A6636.
Natarajan A, Shah P, Mirrakhimov AE, Hussain N. Eosinophilic pneumonia associated with concomitant cigarette and marijuana smoking. BMJ Case Rep. 2013;2013:bcr013009001. https://doi.org/10.1136/bcr-2013-009001.
Siddiqui F, Khan T, Siddiqui A, Weisel S. Lung pathology fellow case report poster—lung pathology. Chest J. 2016;150(4):783. https://doi.org/10.1016/j.chest.2016.08.879.
Golwala H. Marijuana abuse and bullous emphysema. Lung India Indian Chest Soc. 2012;29(1):56–8.
Van Landeghem A, Arys B, Heyse C, Gosselin R. Lung emphysema caused by marijuana smoking. JBR-BTR. 2012;95:166–7.
Tashkin DP. Smoked marijuana as a cause of lung injury. Monaldi Arch Chest Dis. 2005;63:93–100.
Gargani Y, Bishop P, Denning DW. Too many mouldy joints—marijuana and chronic pulmonary aspergillosis. Mediterr J Hematol Infect Dis. 2011;3(1): e2011005. https://doi.org/10.4084/MJHID.2011.005.
Kagen SL, Kurup VP, Sohnle PG, Fink JN. Marijuana smoking and fungal sensitization. J Allergy Clin Immunol. 1983;71:389–93. https://doi.org/10.1016/0091-6749(83)90067-2.
Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001;103(23):2805–9.
Aronow W, Cassidy J. Effect of smoking marihuana and of a high-nicotine cigarette on angina pectoris. Clin Pharmacol Ther. 1975;17(5):549–54.
Petronis KR, Anthony JC. An epidemiologic investigation of marijuana- and cocaine-related palpitations. Drug Alcohol Depend. 1989;23(3):219–26.
Singhm GK. Atrial fibrillation associated with marijuana use. Pediatr Cardiol. 2000;21(3):284.
Kosior DA, Filipiak KJ, Stolarz P, Opolski G. Paroxysmal atrial fibrillation following marijuana intoxication: a two-case report of possible association. Int J Cardiol. 2001;78(2):183–4.
Rezkalla SH, Sharma P, Kloner RA. Coronary no-flow and ventricular tachycardia with habitual marijuana use. Ann Emerg Med. 2003;42(3):365–9.
Cooles P, Michaud R. Stroke after heavy cannabis smoking. Postgrad Med J. 1987;63(740):511.
Zachariah SB. Stroke after heavy marijuana smoking. Stroke. 1991;22(3):406–9.
Barnes D, Palace J, O’Brien MD. Stroke following marijuana smoking. Stroke. 1992;23(9):1381.
Mouzak A, Agathos P, Kerezoudi E, Mantas A, Vourdeli-Yiannakoura E. Transient ischemic attack in heavy cannabis smokers—how ‘safe’ is it? Eur Neurol. 2000;44(1):42–4.
Nahas GG. Cannabis arteritis. N Engl J Med. 1971;284(2):113.
Disdier P, Granel B, Serratrice J, et al. Cannabis arteritis revisited—ten new case reports. Angiology. 2001;52(1):1–5.
Aryana A, Williams D. Marijuana as a trigger of cardiovascular events: speculation or scientific certainty? Int J Cardiol. 2007;118:141–4.
Owen KP, Sutter ME, Albertson TE. Marijuana: respiratory tract effects. Clin Rev Allergy Immunol. 2014;46(1):65–81. https://doi.org/10.1007/s12016-013-8374-y.
Eissenberg T, Shihadeh A. Waterpipe tobacco and cigarette smoking: direct comparison of toxicant exposure. Am J Prev Med. 2009;37:518–23.
Shihadeh A, Schubert J, Klaiany J, El Sabban M, Luch A, Saliba NA. Toxicant content, physical properties and biological activity of waterpipe tobacco smoke and its tobacco-free alternatives. Tob Control. 2015;24(Suppl 1):i22–30.
Van Dam NT, Earleywine M. Pulmonary function in cannabis users: support for a clinical trial of the vaporizer. Int J Drug Policy. 2010;21:511–3.
He T, Oks M, Esposito M, Steinberg H, Makaryus M. Tree-in-bloom”: severe acute lung injury induced by vaping cannabis oil. Ann Am Thorac Soc. 2017;14(3):468–70. https://doi.org/10.1513/AnnalsATS.201612-974LE.
Malouff JM, Rooke SE, Copeland J. Experiences of marijuana-vaporizer users. Subst Abuse. 2014;35:127–8.
Earleywine M, Barnwell SD. Decreased respiratory symptoms in cannabis users who vaporize. Harm Reduct J. 2007;4:11.
Tashkin D. How beneficial is vaping cannabis to respiratory health compared to smoking? Addiction. 2015;110:1705–11.
https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html. Accessed 13 July 2021
Aldington S, et al. Effects of cannabis on pulmonary structure, function and symptoms. Thorax. 2007;62:1058–63. https://doi.org/10.1136/thx.2006.077081.
https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html. Accessed 13 July 2021